Government should embrace innovation in health care sector, industry members say at ‘Redefining Hong Kong Debate Series’

January 15, 2020
SCMP Updates
Speakers on panel urge authorities to make progress in harnessing artificial intelligence for patient care, or roll out apps to match users with doctors

Such technologies are already available on mainland, with industry insiders saying city risks stagnating if it remains constrained by regulatory framework


Hong Kong’s government should be more open-minded and realise the urgency of innovation in the health care sector, representatives from the medical and pharmaceutical industries said on Wednesday.

They were speaking on a panel at the latest edition of the “Redefining Hong Kong Debate Series”, a forum held in Central and organised by the South China Morning Post.

Speakers envisioned Hong Kong in the next five years to make progress in health care technology, such as harnessing artificial intelligence to interpret imaging scans, or rolling out Uber-like mobile apps to match patients with doctors – a service already available in mainland China.

The Hong Kong government has set out policy directions to encourage technological development in health care in recent years, including the setting up of a big data analytics platform under the Hospital Authority. This initiative includes establishing a health technologies research cluster in Science Park, and encouraging a smart hospital approach.

But speakers at the forum on Wednesday urged stakeholders, including the government, to do more for innovation.

Felix Lee Kar-chung, executive director of UMP Healthcare Holdings, which provides medical and health care services in Hong Kong, Macau and mainland China, said local infrastructure for technology was lagging.

“It’s about the whole population understanding what the adoption of technology really means. It requires you to challenge your organisational structure,” he said.

Lee pointed out that it had been difficult to bring in new technologies such as virtual care or patient monitoring through AI – used on the mainland – because of regulatory constraints.

Daniel Thurley, vice-president of the Hong Kong Association of the Pharmaceutical Industry and Hong Kong and Macau general manager of Swiss pharmaceutical Roche, said the sector had been transparent in sharing data of clinical trials with researchers, without any privacy breaches.

“It shows these things are possible,” he added.

UMP’s Lee also urged the government to understand the urgency to adopt medical technologies.

“It’s proven that globally and across the border, and in the US and Britain, adopting virtual care technology and remote monitoring of patients ... [can bring benefits],” Lee said, noting that technology could help reduce the burden of costs on the health care system.

Lee also said he hoped the government would allow people in Hong Kong to use electronic health data for preventive purposes. For instance, users could voluntarily share their data for diagnosis and also include daily behavioural information for more insight.

Continue Reading

 
About South China Morning Post 

South China Morning Post is a leading global news company that has reported on China and Asia for more than a century. Founded in 1903, SCMP is headquartered in Hong Kong, where it is the city’s newspaper of record, with a growing correspondent staff across Asia and the United States. Its editorial teams are powered by emerging digital technologies to create innovative ways to tell Asia’s most important and compelling stories.
Against the backdrop of shifting discovery and consumption behaviours, SCMP reaches users across distributed media platforms including scmp.com, smartphone and tablet apps, social media and messaging platforms, as well as our flagship newspaper.  SCMP is also home to Abacus, a digital news brand focused on China's tech industry; Inkstone, a daily news brief for those curious about China's growing impact around the world; and Goldthread, a content platform with a focus on food, travel and culture in China.